Accolade/ACCD

$10.75

5.18%
-
1D1W1MYTD1YMAX

About Accolade

Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.

Ticker

ACCD

Sector

Healthcare

Trading on

NASDAQ

Industry

Healthcare Facilities

CEO

Rajeev Singh

Employees

2,370

Headquarters

Plymouth meeting, United States

Accolade Metrics

BasicAdvanced
$791.11M
Market cap
-
P/E ratio
-$1.65
EPS
2.08
Beta
-
Dividend rate

What the Analysts think about Accolade

Analyst Ratings

Majority rating from 16 analysts.
Buy

Price Targets

Average projection from 14 analysts.
39.53% upside
High $18.00
Low $12.00
$10.75
Current price
$15.00
Average price target

Accolade Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-21.14% profit margin
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$99.3M
2.58%
Net income
$-21M
-35.98%
Profit margin
-21.14%
-37.6%

Accolade Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 36.67%
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
-$0.42
-$0.52
-$0.43
-$0.28
-
Expected
-$0.42
-$0.62
-$0.54
-$0.44
-$0.07
Surprise
-0.71%
-16.12%
-19.84%
-36.67%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Accolade stock

Buy or sell Accolade stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing